• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

VR startup Karuna Labs Raises $3 Million in Seed Funding to Help Over 30 Million Americans Suffering From Chronic Pain

Share:

September 24, 2019

Chronic pain currently affects over 30 million Americans. Enter Karuna Labs, a tech startup using immersive virtual reality technology to tackle the critical and debilitating health issue of chronic pain, without the need for opioid pain relief or the need for costly invasive surgeries.

Today, Karuna Labs announced it has raised $3M in seed funding. The funding is going towards Karuna Labs’ clinical validation studies as well as further developing the company’s technology and medical/gaming team.

Founded by neuroscientist turned VR engineer Lincoln Nguyen, the San Francisco, California-based Karuna Labs helps patients experiencing anything from MS to the aftermath of a stroke regain movement and strength through its VR technology. Karuna Labs creates personalized chronic pain management programs using Virtual Reality (VR) technology that retrains the brain to perceive movement as non-threatening. Designed to restore function, Karuna Pro is used in clinics around the country, while Karuna Home is offered direct-to-patients for home use through workers’ compensation insurance.

Benefits of Karuna’s treatment for chronic pain (which affects 30M Americans) includes increased patient adherence to physical therapy, the reduction of opioid prescribing, and less use of invasive procedures.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Karuna Labs, creator of personalized functional restoration and chronic pain management programs using Virtual Reality (VR) technology to retrain the brain, today announces $3 million in seed funding, led by Baseline Ventures, with investments from Anorak Ventures, the AET Fund, the Hustle Fund, Correlation Ventures, and Dreamit Ventures.

“Karuna Labs is using immersive virtual reality technology to tackle the critical and debilitating health issue of chronic pain, without the need for opioid pain relief or the need for costly invasive surgeries,” said Steve Anderson, Founder of Baseline Ventures. “We’re proud of this innovative team comprised of medical and technology professionals who’ve come together to expand the reach and impact on the neurorehabilitation industry.”

In addition to supporting Karuna Labs’ clinical validation, the funding will be used to further develop the technology and the team. The company has recently added industry experts from the medical and gaming industries to its team, including Dr. James Petros, Chief Medical Officer, and Andy Riedel, Chief Technology Officer.

Dr. Petros specializes in interventional pain management and musculoskeletal care and is triple board-certified in Physical Medicine & Rehabilitation (Physiatry), Pain Medicine, and Regenerative Medicine, and brings his expertise in comprehensive pain and injury management to Karuna Labs. He is also the founder and CEO of Allied Pain & Spine Institute.

Riedel is a 30-year gaming industry veteran and has spent his career creating immersive experiences, games, and communities, as well as highly scalable server infrastructure for both mobile and web at companies including PlayStudios, Kabam, and Zynga.

“These important milestones continue to solidify our leading role in changing how chronic pain is treated and patients’ ability to regain their quality of life,” said Lincoln Nguyen, CEO of Karuna Labs. “We’re establishing a new first line of defense against chronic pain and remain focused on the lives we’re able to change through our technology while reducing the need for invasive procedures and opioid dependence.”

Date: September 24, 2019

Source: Tech Startups

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • AbbVie Announces Commencement of Exchange Offers and Consent Solicitations for Allergan NotesAbbVie Announces Commencement of Exchange Offers and Consent Solicitations for Allergan Notes
  • Global Cell and Gene Therapy Manufacturing Services Market Report 2021-2027 – Rising Incidence of Cancer Coupled with the Increasing R&D by Pharmaceutical Companies and Partnerships & AgreementsGlobal Cell and Gene Therapy Manufacturing Services Market Report 2021-2027 – Rising Incidence of Cancer Coupled with the Increasing R&D by Pharmaceutical Companies and Partnerships & Agreements
  • Kashiv Pharma Acquires Adello Biologics and Becomes Kashiv BioSciencesKashiv Pharma Acquires Adello Biologics and Becomes Kashiv BioSciences
  • Pharma-grade Synthetic Camphor Market Size, Share, Industry Trends, Growth Insight, Share, Competitive Analysis, Statistics, Regional, And Industry ForecastPharma-grade Synthetic Camphor Market Size, Share, Industry Trends, Growth Insight, Share, Competitive Analysis, Statistics, Regional, And Industry Forecast
  • Walmart Looks to Virtual Care with Acquisition of Telemedicine Company MeMDWalmart Looks to Virtual Care with Acquisition of Telemedicine Company MeMD
  • Symplr Closes Acquisition Of ComplyTrackSymplr Closes Acquisition Of ComplyTrack
  • Insomnia Drugs Market Industry | Covid-19 – Global Impact and Forecast Report 2020-2025Insomnia Drugs Market Industry | Covid-19 – Global Impact and Forecast Report 2020-2025
  • Lilly’s Targeted RET Drug Shrinks Tumors In Lung Cancer TrialLilly’s Targeted RET Drug Shrinks Tumors In Lung Cancer Trial

Trending This Week

  • Novartis Drops Eye Disease Gene Therapy from $800M Gyroscope Acquisition
  • GSAC Engineering Acquires Key Intellectual Property and Assets from Duos Technologies GroupGelStat’s Subsidiary, GSAC Engineering, Launches Intelligent Correctional Facilities Automation Systems (iCAS) in the Industrial Security Market
  • Life Launches AI Clinical Trial Matching Assistant for Cancer
  • 79% of Healthcare Execs Believe Most Drug Diversion Goes Undetected
  • Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine
  • FDA Releases Updated Final Guidance for its Breakthrough Devices Program

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications